YouTube Facebook LinkedIn Google+ Twitter Xingrss  

KCR Training Program Recognized by TransCelerate

KCR GCP Investigator Site Personnel Training meets the requirements set by TransCelerate member companies

WARSAW, POLAND - Jun 30, 2014 - Warsaw - 30 June 2014 - KCR, European Contract Research Organization, announces today that its International Conference on Harmonization Good Clinical Practice (ICH GCP) Investigator Site Personnel Training has been recognized by TransCelerate BioPharma Inc. TransCelerate’s members include some of the world’s largest pharmaceutical companies, including Astra Zeneca, Lilly, GlaxoSmithKline, Johnson and Johnson, Pfizer, Roche, Sanofi and more.

KCR’s Training Department prepared the ICH GCP Training in order to assure an equal level of GCP awareness among clinical investigators. The Training has been successfully acknowledged by TransCelerate in the following statement: “This ICH E6 GCP Investigator Site Training meets the Minimum Criteria for ICH GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition of GCP training among trial sponsors.”

By the use of workshops and discussions situated within the GCP context the KCR’s Training promotes meaningful educational experience that enables participants to engage actively in a learning process. “At KCR we understand that professional qualifications of all parties involved in conducting clinical trials are crucial for study success. KCR remains committed to support and contribute to initiatives such as TransCelerate. TransCelerate activities will be critical to support efforts to reduce costs of clinical trials and increase the standardization,” commented Mike Jagielski, President and CEO, KCR.

KCR Training Department provides a wide array of learning activities to enhance development of clinical operations employees. “All our trainings are focused on process approach providing participants with good understanding of interrelating activities in a clinical trial lifecycle,” added Emilia Wojanczyk, Head of QA and Training Department, KCR. “We are very happy that our ICH GCP Training qualifies for mutual recognition by member companies.”

TransCelerate BioPharma Inc. is a non-profit organization dedicated to accelerating and simplifying the research and development of innovative new therapies. The organizations’ mission is to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines.

 

If you would like to learn more about KCR ICH GCP Investigator Site Personnel Training recognized by TransCelerate or receive information on other KCR trainings and services, please contact Joanna Lewandowska, PR & Marketing, KCR, at joanna.lewandowska@kcrcro.com.

 

About KCR

KCR is a European Contract Research Organization (CRO) and strategic solutions provider for companies who are looking for a reliable alternative to global CROs. Almost 300 professionals operating across 18 countries in Europe as well as the U.S. offer full service capabilities for Phase I-IV Clinical Development Projects across a wide range of therapeutic areas. KCR also operates as a Functional Service Provider with strategic and tactical solutions in Clinical Operations, Data Management and Expert Sourcing. Our service portfolio includes delivery of regional and local Post-Marketing Clinical Services according to the clients’ needs. KCR supports 12 of the Top 20 Global Pharma companies with its services on long standing global or local contracts.

For more information please visit: www.kcrcro.com.

Contact:

Joanna Lewandowska

PR & Marketing Manager

KCR

P: +48 605 053 164

Email: joanna.lewandowska@kcrcro.com

www.kcrcro.com

 

 

 


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.